A carregar...
Subcutaneous Administration of Bortezomib: A Pilot Survey of Oncology Nurses
Subcutaneous (SC) administration of the proteasome inhibitor bortezomib was approved in the United States and European Union in 2012. There is limited guidance regarding how to administer SC bortezomib and a general lack of clear direction on optimal techniques for administering SC chemotherapy inje...
Na minha lista:
| Publicado no: | J Adv Pract Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Harborside Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677804/ https://ncbi.nlm.nih.gov/pubmed/26705492 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|